Biotech Short Candidates | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Biotech Short Candidates

An SI Board Since December 2000

Posts	SubjectMarks	Bans
897	95	0

Emcee: tuck	Type: Unmoderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
872	JUNO, up 20% in sympathy with KITE, which is being bought out, seems like an obv	tuck	-	8/28/2017
871	Good question. Most likely these are results from a backtesting program, with p	tuck	-	5/15/2012
870	Were the details of the short-and-cover algorithm developed prospectively?	DewDiligence_on_SI	-	5/14/2012
869	Interesting article on shorting (or selling longs to seek a lower re-entry price	tuck	-	5/14/2012
868	Just because PFE screwed up royally in the past (Macugen, Indiplon, Exubera, etc	DewDiligence_on_SI	-	10/27/2008
867	>>Medivation: some experts skeptical of Dimebon's chances of attaining	tuck	-	10/27/2008
866	From WSJ: Medivation said Dimebon seems to work by protecting the functioning o	Doc Bones	-	7/31/2008
865	ICAD has been way more interesting this year than ASCO. Medivation posts result	tuck	-	7/30/2008
864	Medivation posts cloudy results in Huntington's trial. It had "inadver	tuck	-	7/8/2008
863	Short PHRM at ~$43. Small starter position; may add. Edit: did add ~$44.30.	tuck	-	8/3/2007
862	Anyone think PHRM might be a worthy short here? Vidaza just came in with excell	tuck	-	8/3/2007
861	Paion's data is horrendous. Surprising the dsmb didn't stop the trial.	rkrw	-	5/31/2007
860	FWIW, I hadn't seen that news. I don't follow frx either. <i>(	keokalani'nui	-	5/31/2007
859	Thanks for the pointer. I have heard that some consider FRX to be cutting corne	tuck	-	5/31/2007
858	The only put position Aticus held at 3/31/07 is in FRX. If it is a good idea	keokalani'nui	-	5/31/2007
857	Stockpickr The Top 10 Biotech Short Squeezes By James Altucher RealMoney.com Co	Doc Bones	-	5/31/2007
856	All they need to say next is that it works for obesity too! Jon	Robohogs	-	5/5/2007
855	[Copying from another board....] Alzheimer's Trial Boosts Its Outlook BY P	sim1	-	5/5/2007
854	>>Medivation: Dimebon Trial Patient Subsets Improved >MDVN Last update:	tuck	-	5/3/2007
853	Whatever's going on with the MDVN options, the stock is readily borrowable,	tuck	-	4/30/2007
852	In the aesthetic-medicine arena, THRM, ARTE, and OMPI look enticing. I’ve posted	DewDiligence_on_SI	-	4/30/2007
851	This looks like a short in the making, but it hasn’t IPO’d yet (and maybe never	DewDiligence_on_SI	-	4/30/2007
850	It's got to be more sophisticated than Fidelity's banality - and the dis	tom pope	-	4/26/2007
849	Nothing I say or do is very sophisticated, just misc thoughts.	kenhott	-	4/26/2007
848	The AVNR would have worked nicely - I was not convinced yet. Such is life! Jon	Robohogs	-	4/25/2007

Go to reply# or date (mm/dd/yy):